US Department of Health and Human Services.

Bone Health and

Osteoporosis: A Report of the Surgeon General. Rockville, MD: US
Department of Health and Human Services, Office of Surgeon General; 2004.
2. Khosla S, Riggs BL. Pathophysiology of age-related bone loss and
osteoporosis. Endocrinol Metab Clin N Am 2005;34:1015-30.
3. National Osteoporosis Foundation. Fast facts. Available at:
http://www.nof.org/node/40. Accessed July 23, 2013.
4. Adachi JD. Impact of prevalent fractures on quality of life: baseline results
from the global longitudinal study of osteoporosis in women. Mayo Clin Proc
2010;85(9):806-13.
5. Burge RT, Dawson-Hughes B, Solomon D, Wong JB, King AB, Tosteson
ANA. Incidence and economic burden of osteoporotic fractures in United
States, 2005-2025. J Bone Min Res 2007;22:465-75.
6. Kemenkes. Pedoman Pengendalian Osteoporosis. Jakarta: Departemen
Kesehatan Indonesia; 2008.
7. Wiknjosastro H. Wanita dalam berbagai Masa Kehidupan. In: Saifuddin AB,
Rachimadhi T, editors. Ilmu Kandungan. Jakarta: PT. Bina Pustaka Sarwono
Prawirohardjo;2009.p.128-31.
8. Kastelan D, Korsic M. High prevalence rate of pituitary incidentaloma: Is it
associated with the age-related decline of the sex hormones levels?.Med
Hypotheses 2007;69:307-9.
9. Bjornerem A, Bjorn S, Midtby M. Endogenous sex hormones in relation to
age, sex, lifestyle factors, and chronic diseases in a general population: the
Tromso study. J Clin Endocrinol Metab 2004;89:603947.
10. Van der Linden JC, Weinans H. Effects of microarchitecture on bone strength.
Curr Osteoporos Rep 2007;5:56-61.
11. Harada S, Rodan GA. Control of osteoblast function and regulation of bone
mass. Nature 2003;432(6937):349-55.
12. Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone
formation. Annu Rev Cell Dev Biol 2009;25:629-48.
13. Dallas SL, Bonewald LF. Dynamics of the transition from osteoblast to
osteocyte. Ann N Y Acad Sci 2010;1192:437-443.
14. Crockett JC, Mellis DJ, Scott D I, Helfrich MH. (2011).New knowledge on
critical osteoclast formation and activation pathways from study of rare
genetic diseases of osteoclasts: focus on the RANK/RANKL axis. Osteoporos
Int 2011;1:1-20.
15. Seeman E, Delmas PD. Bone quality-the material and structural basis of bone
strength and fragility. N Engl J Med 2006;354:2250-61.
16. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an
inflammatory tale. J Clin Invest 2006;116:1186-94.
17. Zallone A. Direct and indirect estrogen actions on osteoblasts and osteoclasts.
Ann N Y Acad Sci 2006;1068:173-9.
41

18. Krum SA, Miranda-Carboni GA, Hauschka PV, Carroll JS, Lane TF,
Freedman LP, et al. Estrogen protects bone by inducing Fas ligand in
osteoblasts to regulate osteoclast survival. EMBO J 2008;27:535-45.

19. You L. Osteocytes as mechanosensors in the inhibition of bone resorption due

to mechanical loading. Bone 2008;42:172-9.
20. Bradford PG. Estrogen regulation of apoptosis in osteoblasts. Physiol
Behav 2010;99:181-5.
21. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, et al.
Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas
ligand in osteoclasts. Cell 2007;130:811-23.
22. Bonnelye E, Aubin JE. Estrogen receptor-related receptor alpha: a mediator
of estrogen response in bone. J Clin Endocrinol Metab 2005;90:311521.
23. Goderie-Plomp HW. Endogenous sex hormones, sex hormone-binding
globulin, and the risk of incident vertebral fractures in elderly men and
women: the Rotterdam Study. J Clin Endocrinol Metab 2004;89:32619.
24. Carbone LD. Association between bone mineral density and the use of
nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase
selectivity. J Bone Miner Res 2003;18:1795802.
25. Mbalaviele G. Beta-Catenin and BMP-2 synergize to promote osteoblast
differentiation and new bone formation. J Cell Biochem 2005;94:40318.
26. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ,Bouxsein ML,et al. High
bone mass in mice expressing a mutant LRP5 gene. J Bone Miner
Res 2003;18:960-74.
27. Leibbrandt A, Penninger JM. RANK/RANKL: regulators of immune
responses and bone physiology. Ann N Y Acad Sci 2008;1143:123-50.
28. Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, et
al. Human osteoclast-poor osteopetrosis with hypogamma-globulinemia due
to TNFRSF11A (RANK) mutations. Am J Hum Genet 2008; 83:64-76.
29. Kanis JA, Johansson H, Odn A, Johnell O, De LAet C, Eisman JA, et al. A
familiy history of fracture and fracture risk: a meta-analysis. Bone
2004;35:1029-37.
30. Kanis JA, De Laet C, Delmas P, Garnero P, Johansson H, Johnell O, et al. A
meta-analysis of previous fracture and fracture risk. Bone 2004 35;375-82.
31. Kanis J A, Johansson H, Odn A, Johnell O, De Laet C, Melton LJ III, et al. A
meta-analysis of prior corticosteroid use and fracture risk. J Bone and Miner
Res 2004;19:893-9.
32. Kanis JA. Johansson H, Johnell O, Odn A, De Laet C, Eisman J, et al.
Alcohol intake as a risk factor for fracture. Osteoporos Int 2005;16:737-42.
33. Berg KM. Association between alcohol consumption and both osteoporotic
fracture and bone density. Am J Med 2008;121:406-18.
34. Kanis JA, Johnell O, Odn A, Johansson H, De Laet C, Eisman JA, et al.
Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005;16:155-62.
35. Dawson-Hughes B, Heaney RP, Holick MF. Estimates of optimal vitamin D
status. Osteoporos Int 2005;16:713-6.
36. Jackson RD. Calcium plus vitamin D supplementation and the risk of
fractures. N Engl J Med 2006;354:669-83.
42

37. Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporos

Int 2005;16 Suppl 2:S3-S7.

38. International Osteoporosis Foundation. Osteoporosis: whos at risk?.

Available at: http://www.iofbonehealth.org/whos-risk. Accessed August 22,
2013.
39. International Osteoporosis Foundation. Osteoporosis and musculoskeletal
disorders. Available at: http://www.iofbonehealth.org/what-is-osteoporosis.
Accessed August 22, 2013.
40. Siris ES, Brenneman SK, Barret-Connor E, Miller PD, Sajjan S, Berger ML,
et al. The effect of age and bone mineral density on the absolute, excess, and
relative risk of fracture in postmenopausal women aged 5099: results from
the National Osteoporosis Risk Assessment (NORA). Osteoporos Int
2004;17:565-74.
41. Recker R, Lappe J, Davies KM, Heaney R. Bone Remodeling Increases
Substantially in the Years After Menopause and Remains Increased in Older
Osteoporosis Patients. J Bone Miner Res 2004;19:1628-33
42. Kanis JA, Johnell O, Oden A, Johansson H, Laet CD, Eisman A, et al.
Smoking and fracture risk: a meta-analysis. Osteporos Int 2005;16:155-62
43. Hernandez-Rauda R, Martinez-Garcia S. Osteoporosis-related life habits and
knowledge about osteoporosis among women in El-Salvador: A cross
sectional study. BMC Muskuloskelet Disord 2004;5:29
44. Gur A, Saraj AJ, Nas K, Cevik R. The relationship between educational level
and bone mineral density in postmenopausal women. BMC Family Practice
2004; 5:18
45. Kutsal YG, Atalay A, Arslan S, Basaran A, Cantrk F, Cindas A, et al.
Awareness of osteoporotic patients. Osteoporos Int 2005; 16: 128-33